CD24 and breast carcinoma: In this study, CD24 antibody as well-known biomarker was thoroughly conjugated to the modified gold nanoparticle (CD24-PEGylated Au-NPs ) for recognition of the cancer, and also implemented as a targeted Nano contrast to detect breast cancer cells ( 4T1 cells) in both in vitro and in vivo experiments.